10 High Growth High Margin Stocks to Buy Now

Page 9 of 10

2. Eli Lilly & Company (NYSE:LLY)

Operating Margin (TTM): 45.56%

5-Year Revenue Growth Rate: 21.58%

Number of Hedge Fund Holders: 114

Eli Lilly & Company (NYSE:LLY) ranks among the best high growth high margin stocks to buy now. Deutsche Bank retained its Buy rating and $1,200 price target for Eli Lilly & Company (NYSE:LLY) on February 4, citing the pharmaceutical giant’s strong fiscal year 2026 projections.

Eli Lilly & Company (NYSE:LLY) posted revenues of around $19.3 billion in the fourth quarter of 2025, exceeding Street projections of $18 billion, thanks mostly to strong results from its diabetes and obesity drugs Mounjaro and Zepbound.

The company announced fiscal year 2026 revenue forecast of $80-$83 billion and non-GAAP EPS forecasts of $33.50-$35.00 per share, beating the analyst average projections of $78 billion in revenue and $33.09 per share.

Eli Lilly & Company (NYSE:LLY) further confirmed the introduction of Orforg in the US in Q2 2026 as well as the implementation of Medicare’s obesity coverage on July 1, 2027, in addition to the submission of Orforg’s European file for Type 2 diabetes.

Eli Lilly & Company (NYSE:LLY) is a major global pharmaceutical company that develops, manufactures, and distributes a wide range of drugs. Founded in 1876, it has grown to become one of the world’s largest pharmaceutical companies.

Page 9 of 10